HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway

Oncogene

Volumn 23, Issue 28, 2004, Pages 4807-4817

  Finzer, Patrick ^a   Krueger, Andreas ^b,e   Stöhr, Michael ^c   Brenner, Dirk ^b   Soto, Ubaldo ^a   Kuntzen, Christian ^d   Krammer, Peter H ^b   Rösl, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Abteilung Immungenetik   (Germany)

^c Forschungsschwerpunkt Zytometrie   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cervical carcinoma cells; HDAC inhibitors; Human papillomavirus

Indexed keywords

CASPASE; CYCLIN E; HISTONE DEACETYLASE INHIBITOR; ISOPROTEIN; PROTEIN P107; PROTEIN P130; PROTEIN P53; PROTEIN P73; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; ENZYME INHIBITOR; FC RECEPTOR; HISTONE DEACETYLASE; NUCLEAR PROTEIN; PRIMER DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WART VIRUS; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HELA CELL; INTRACELLULAR MEMBRANE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PATHOGENICITY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

APOPTOSIS; BASE SEQUENCE; CELL CYCLE PROTEINS; DNA PRIMERS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME INHIBITORS; GENES, TUMOR SUPPRESSOR; HELA CELLS; HISTONE DEACETYLASES; HUMANS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MITOCHONDRIA; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PROTEIN ISOFORMS; RECEPTORS, FC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 3042723615     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207620     Document Type: Article

References (73)

1. Aguilar-Lemarroy A, Kirchhoff S, Whitaker N, Gariglio P, zur Hausen H, Krammer PH and Rösl F. (2001). Int. J. Cancer, 93, 823-831.
2. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR and Wahl GM. (1995). Proc. Natl. Acad. Sci. USA, 92, 5436-5440.
3. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. (1998). Nature, 395, 124-125.
4. Bernard HU. (2002). Antivirus Ther., 7, 219-237.
5. Boutillier AL, Trinh E and Loeffler JP. (2000). Oncogene, 19, 2171-2178.
6. Boyer SN, Wazer DE and Band V. (1996). Cancer Res., 56, 4620-4624.
7. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T. (1998). Nature, 391, 597-601.
8. Brooks CL and Gu W. (2003). Curr. Opin. Cell Biol., 15, 164-171.
9. Brummelkamp TR, Bernards R and Agami R. (2002). Science, 296, 550-553.
10. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C and La Thangue NB. (2001). Nat. Cell Biol., 3, 667-674.
11. Chen C and Okayama H. (1987). Mol. Cell. Biol., 7, 2745-2752.
12. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
13. Classon M and Dyson N. (2001). Exp. Cell Res., 264, 135-147.
14. Cory S and Adams JM. (2002). Nat. Rev. Cancer, 2, 647-656.
15. Dean PN and Jett JH. (1974). J. Cell. Biol., 60, 523.
16. Dhein J, Walczak H, Baumler C, Debatin KM and Krammer PH. (1995). Nature, 373, 438-441.
17. Dyson N, Howley PM, Münger K and Harlow E. (1989). Science, 17, 934-937.
18. Eichhorst S, Müller M, Li-Weber M, Schulze-Bergkamen H, Angel P and Krammer PH. (2000). Mol. Cell. Biol., 20, 7826-7837.
19. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A and Trouche D. (1998). Proc. Natl. Acad. Sci. USA, 95, 10493-10498.
20. Finzer P, Kuntzen C, Soto U, zur Hausen H and Rösl F. (2001). Oncogene, 20, 4768-4776.
21. Finzer P, Stöhr M, Seibert N and Rösl F. (2003). J. Cancer Res. Clin. Oncol., 129, 107-113.
22. Finzer P, Ventz R, Kuntzen C, Seibert N, Soto U and Rösl F. (2002). Virology, 304, 265-273.
23. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME and Debatin KM. (1998). Cell Death Differ., 5, 884-893.
24. Gomez-Manzano C, Mitlianga P, Fueyo J, Lee H-Y, Hu M, Spurgers KB, Glass TL, Koul D, Liu T-J, McDonnell J and Yung WKA. (2001). Cancer Res., 61, 6693-6697.
25. Green DR and Evan GI. (2002). Cancer Cell, 1, 19-30.
26. Griffiths DJ, Venables PJ, Weiss RA and Boyd MT. (1997). J. Virol., 71, 2866-2872.
27. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK and Israel MA. (1995). EMBO J., 14, 461-472.
28. Harbour JW and Dean DC. (2000). Nat. Cell Biol., 2, 65-67.
29. Hengartner MO. (2000). Nature, 407, 770-776.
30. Hwang SG, Lee D, Kim J, Seo T and Choe J. (2002). J. Biol. Chem., 277, 2923-2930.
31. Igney FH and Krammer PH. (2002). Nat. Rev. Cancer, 2, 277-288.
32. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsal KY, Jacks T, Vousden KH and Kaelin WG. (2000). Nature, 407, 645-648.
33. Janicke RU, Walker PA, Lin XY and Porter AG. (1996). EMBO J., 15, 6969-6978.
34. Krammer PH. (2000). Nature, 407, 789-795.
35. Lin K-I, Baraban JM and Rata RR. (1998). Cell Death Differ., 5, 577-583.
36. Luo J, Su F, Chen D, Shiloh A and Gu W. (2000). Nature, 408, 377-381.
37. Mantovani F and Banks L. (2001). Oncogene, 20, 7874-7887.
38. Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T and Kelly WK. (2001). Nat. Rev. Cancer, 1, 194-202.
39. Martinez-Balbas MA, Bauer U-M, Nielsen SJ, Brehm A and Kouzarides T. (2000). EMBO J., 19, 662-671.
40. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K and Giacca M. (2000). J. Biol. Chem., 275, 10887-10892.
41. Melino G, De Laurenzi V and Vousden KH. (2002). Nat. Rev. Cancer, 2, 605-615.
42. Meriin AB, Gabai VL, Yaglom J, Shifrin VI and Sherman MY. (1998). J. Biol. Chem., 273, 6373-6379.
43. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K. (2001). Nat. Cell Biol., 3, 552-558.
44. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Vigo E, Oliner JD and Helin K. (2001). Genes Dev., 15, 267-285.
45. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL. (2001). Oncogene, 20, 7888-7898.
46. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L and Woodworth CD. (2001). J. Virol., 75, 4283-4296.
47. Nevins JR. (1998). Cell Growth Differ., 9, 585-593.
48. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C. (1991). J. Immunol. Methods, 139, 271-279.
49. Phillips AC and Vousden KH. (2001). Apoptosis, 6, 173-182.
50. Phillips AC, Ernst MK, Bates S, Rice NR and Vousden KH. (1999). Mol. Cell, 4, 771-781.
51. Pisani P, Bray F and Parkin DM. (2002). Int. J. Cancer, 97, 72-81.
52. Pomerantz J, Schreiber-Agus N, Leigeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998), Cell, 92, 713-723.
53. Re D, Hofmann A, Wolf J, Diehl V and Staratschek-Jox A. (2000). Exp. Hematol., 28, 31-35.
54. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL. (1994). Cell, 78, 761-771.
55. Rogoff HA, Pickering MT, Debatis ME, Jones S and Kowalik TF. (2002). Mol. Cell. Biol., 22, 5308-5318.
56. Rosato RR, Almenara JA and Grant S. (2003). Cancer Res., 63, 3637-3645.
57. Salvioli S, Ardizzoni A, Franceschi C and Cossarizza A. (1997). FEBS Lett., 411, 77-82.
58. Scaffidi C, Fulda S, Srinivasa A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
59. Scaffidi C, Medema JP, Krammer PH and Peter ME. (1997). J. Biol. Chem., 272, 26953-26958.
60. Soto U, Das BC, Lengert M, Finzer P, zur Hausen H and Rösl F. (1999). Oncogene, 18, 3187-3198.
61. Stanelle J, Stiewe T, Theseling CC, Peter M and Pützer BM. (2002). Nucleic Acids Res., 30, 1859-1867.
62. Stoehr M, Vogt-Schaden M, Knobloch M, Vogel R and Futterman G. (1978). Stain Technology, 55, 205-215.
63. Tan X, Martin SJ, Green DR and Wang J. (1997). J. Biol. Chem., 272, 9613-9616.
64. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH. (1989). Science, 245, 301-305.
65. Trimarchi JM and Lees JA. (2002). Nat. Rev. Mol. Cell. Biol., 3, 11-20.
66. Van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P. (2002). Cell Death Differ., 9, 1031-1042.
67. Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M and Thompson CB. (2000). Proc. Natl. Acad. Sci. USA, 97, 4666-4671.
68. Walczak H and Krammer PH. (2000). Exp. Cell Res., 256, 58-66.
69. Wang QM, Feinman R, Kashanchi F, Houghton JM, Studzinski GP and Harrison LE. (2000). Clin. Cancer Res., 6, 2951-2958.
70. Wharton W, Savell J, Cress WD, Seto E and Pledger WJ. (2000). J. Biol. Chem., 275, 33981-33987.
71. Yang A, Kaghad M, Caput D and McKeon F. (2002). Trends Genet., 18, 90-95.
72. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.
73. zur Hausen H. (2002). Nat. Rev. Cancer, 2, 342-350.